Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis

被引:5
|
作者
Behrens, Edward M.
Beukelman, Timothy
Paessler, Michele
Cron, Randy Q.
机构
[1] Childrens Hosp, Dept Pediat, Div Rheumatol, Philadelphia, PA 19104 USA
[2] Childrens Hosp, Dept Pathol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
关键词
macrophage activation syndrome; systemic juvenile idiopathic arthritis; hemophagocytosis; CD163; antigen; bone marrow aspirate; hemophagocytic lymphohistiocytosis;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Macrophage activation syndrome (MAS) is a well described, but purportedly uncommon manifestation of systemic juvenile idiopathic arthritis (SJIA). There is evidence to suggest that macrophage activation is integral to the pathogenesis of SJIA, Accordingly, many patients with SJIA may have evidence of mild MAS that is not appreciated clinically. We investigated the prevalence of occult MAS in children with SJIA by reviewing bone marrow aspirates (BMA). Methods. Patients diagnosed with SJIA who underwent bone marrow aspiration were identified retrospectively. Patients admitted with a diagnosis of fever of unknown origin and discharged with a diagnosis other than SJIA or malignancy, and who had a BMA, were identified as controls. The BMA were reviewed by a single hematopathologist for evidence of MAS, ranging from activated macrophages to frank hemophagocytic cells. Results. Eight of 15 (53%) patients with SJIA had BMA suggestive of MAS. Two of 15 patients (13%) were diagnosed clinically with MAS. Three patients (20%) were noted to have frank hemophagocytosis, only one of whom was diagnosed with MAS clinically. There were no statistically significant differences in the laboratory values for the patients with and without evidence of MAS on BMA. There was no evidence of increased macrophage activity or hemophagocytosis in any of the control BMA. Conclusion. Occult MAS appears to be common in patients with SJIA who undergo BMA. This suggests that macrophage activation may be integral to the pathogenesis of SJIA, with implications for treatment.
引用
收藏
页码:1133 / 1138
页数:6
相关论文
共 50 条
  • [1] Macrophage activation syndrome in systemic juvenile idiopathic arthritis
    Shimizu, Masaki
    IMMUNOLOGICAL MEDICINE, 2021, 44 (04) : 237 - 245
  • [2] Characterization of Patients with Macrophage Activation Syndrome Secondary to Systemic Juvenile Idiopathic Arthritis
    Rogowska, Jagoda
    Kubicka, Jagoda
    Grabowska, Martyna
    Mirocha, Grzegorz
    Roszkiewicz, Justyna
    Smolewska, Elzbieta
    CLINICAL RHEUMATOLOGY, 2025, : 2023 - 2029
  • [3] Dissecting the Heterogeneity of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis
    Minoia, Francesca
    Davi, Sergio
    Horne, AnnaCarin
    Bovis, Francesca
    Demirkaya, Erkan
    Akikusa, Jonathan
    Ayaz, Nuray A.
    Al-Mayouf, Sulaiman M.
    Barone, Patrizia
    Bica, Bianca
    Bolt, Isabel
    Breda, Luciana
    De Cunto, Carmen
    Enciso, Sandra
    Gallizzi, Romina
    Griffin, Thomas
    Hennon, Teresa
    Horneff, Gerd
    Jeng, Michael
    Kapovic, Ageza M.
    Lipton, Jeffrey M.
    Manzoni, Silvia Magni
    Rumba-Rozenfelde, Ingrida
    Magalhaes, Claudia Saad
    Sewairi, Wafaa M.
    Stine, Kimo C.
    Vougiouka, Olga
    Weaver, Lehn K.
    Davidsone, Zane
    De Inocencio, Jaime
    Ioseliani, Maka
    Lattanzi, Bianca
    Tezer, Hasan
    Buoncompagni, Antonella
    Picco, Paolo
    Ruperto, Nicolino
    Martini, Alberto
    Cron, Randy Q.
    Ravelli, Angelo
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (06) : 994 - 1001
  • [4] Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab
    Yokota, Shumpei
    Itoh, Yasuhiko
    Morio, Tomohiro
    Sumitomo, Naokata
    Daimaru, Kaori
    Minota, Seiji
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (04) : 712 - 722
  • [5] Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab
    Fabrizio De Benedetti
    Rayfel Schneider
    Sheila Weitzman
    Clare Devlin
    Kaori Daimaru
    Shumpei Yokota
    Syuji Takei
    Angelo Ravelli
    Pediatric Rheumatology, 12 (Suppl 1)
  • [6] Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus
    Aytac, Selin
    Batu, Ezgi Deniz
    Unal, Sule
    Bilginer, Yelda
    Cetin, Mualla
    Tuncer, Murat
    Gumruk, Fatma
    Ozen, Seza
    RHEUMATOLOGY INTERNATIONAL, 2016, 36 (10) : 1421 - 1429
  • [7] Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus
    Selin Aytaç
    Ezgi Deniz Batu
    Şule Ünal
    Yelda Bilginer
    Mualla Çetin
    Murat Tuncer
    Fatma Gümrük
    Seza Özen
    Rheumatology International, 2016, 36 : 1421 - 1429
  • [8] Treatment for macrophage activation syndrome associated with systemic juvenile idiopathic arthritis in Japan
    Shimizu, Masaki
    Nishimura, Kenichi
    Iwata, Naomi
    Yasumi, Takahiro
    Umebayashi, Hiroaki
    Nakagishi, Yasuo
    Okura, Yuka
    Okamoto, Nami
    Kinjo, Noriko
    Mizuta, Mao
    Yashiro, Masato
    Yasumura, Junko
    Wakiguchi, Hiroyuki
    Kubota, Tomohiro
    Mouri, Mariko
    Kaneko, Utako
    Mori, Masaaki
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (05) : 938 - 945
  • [9] Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis
    Ravelli, A
    Caria, MC
    Buratti, S
    Malattia, C
    Temporini, F
    Martini, A
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (04) : 865 - 867
  • [10] The frequency of macrophage activation syndrome and disease course in systemic juvenile idiopathic arthritis
    Cakan, Mustafa
    Karadag, Serife Gul
    Tanatar, Ayse
    Ayaz, Nuray Aktay
    MODERN RHEUMATOLOGY, 2020, 30 (05) : 900 - 904